St. Vincent & Grenadines Health Press: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on St. Vincent & Grenadines Health Press.

Press releases published on May 12, 2026

May. 12, 2026

BlossomHill Therapeutics to Present Initial Clinical Dose Escalation Data from the Phase 1/1b Trial of BH-30236 in Patients with R/R AML or HR-MDS at EHA2026

Indeterminate GlobeNewswire

May. 12, 2026

Agios to Present New Data at EHA 2026 Reinforcing the Significant Therapeutic Impact of Mitapivat Across Multiple Rare Hemolytic Anemias

Indeterminate GlobeNewswire

May. 12, 2026

Ajax Therapeutics Announces Oral Presentation of Clinical Results from AJX-101, a Phase I study of AJ1-11095, a First-in-Class Type II JAK2 Inhibitor, at the European Hematology Society (EHA) 2026 Congress

Indeterminate GlobeNewswire

May. 12, 2026

Cellectis to Present Clinical Data on Lasme-cel and Eti-cel at EHA 2026 Annual Congress

Indeterminate GlobeNewswire

May. 12, 2026

Cellectis présentera des données cliniques sur lasmé-cel et éti-cel au congrès annuel de l’EHA 2026

Indeterminate GlobeNewswire

May. 12, 2026

Independent Cleveland Clinic Review Finds No Clinically Significant Cardiotoxicity with Moleculin's Annamycin in R/R AML Patients Dosed Beyond Conventional Anthracycline Limits

Indeterminate GlobeNewswire

May. 12, 2026

PayZen Report: Healthcare Financial Pressures Mount as 73% of Systems Elevate Patient Payment Balances to a Top Priority

Indeterminate GlobeNewswire

May. 12, 2026

Four Winners Selected in PerfectServe’s 2026 Nurses of Note Awards Program

Indeterminate GlobeNewswire

May. 12, 2026

Ontra Launches AI-Powered DDQ Solution to Accelerate Investor Diligence for Private Markets Firms

Indeterminate GlobeNewswire

May. 12, 2026

Resolution Therapeutics to showcase key preclinical data on its Regenerative Macrophage Therapy (RMT) RTX001 in oral presentation at ASGCT 2026

Indeterminate GlobeNewswire

May. 12, 2026

JenaValve Appoints Dave Haan as Vice President of Clinical Affairs

Indeterminate GlobeNewswire

May. 12, 2026

Muscular Dystrophy Association Announces $100,000 Investment to Advance LGMD Care at Leading MDA Care Centers with BridgeBio

Indeterminate GlobeNewswire

May. 12, 2026

Connect Biopharma Reports First Quarter 2026 Financial Results and Provides Business Update

Indeterminate GlobeNewswire

May. 12, 2026

LiveWorld Reports First Quarter 2026 Financial Results

Indeterminate GlobeNewswire

May. 12, 2026

PrognomiQ Announces Breakthrough Results for the Early Detection of Lung Cancer in Ongoing Real-World Study for Its Novel Blood Test

Indeterminate GlobeNewswire

May. 12, 2026

Clearmind Medicine Reaches Important Clinical Milestone: 20 Participants Now Treated in Ongoing Phase I/IIa Trial of CMND-100 for Alcohol Use Disorder

Indeterminate GlobeNewswire

May. 12, 2026

Fortis Life Sciences Awards 2026 AbNano® VHH Discovery Grant to Deliver Biosciences for Targeted Drug Delivery Research

Indeterminate GlobeNewswire

May. 12, 2026

ENvue Medical Secures Three-Year Contract Renewal at 12-Hospital U.S. Health Network as the ENvue™ Navigation Platform Becomes Standard of Care

Indeterminate GlobeNewswire

May. 12, 2026

Akari Therapeutics Secures Key European Patent For Its Novel RNA Splicing Modulator ADC Payload, Strengthening Global IP Estate For All Major Global Markets

Indeterminate GlobeNewswire

May. 12, 2026

20/20 BioLabs Exclusively Licenses PSA Velocity Algorithm from the University of South Carolina

Indeterminate GlobeNewswire